Navigation Links
Evidence of a relationship between swimming babies and infections
Date:10/4/2007

In this way, the study shows that allowing babies to swim is possibly not as harmless with regard to infections as has been presumed till now," underlines Dr. Joachim Heinrich. He leads the research unit environmental epidemiology at the GSF Institute for Epidemiology.

Prof. Dr. Dr. H. Erich Wichmann, Director of the GSF Institute of Epidemiology, adds: This is a first indication. Nevertheless, it requires other evidence to be able to achieve consequential results whether the water quality in German swimming-pools protects sufficiently against infections in infants, and, in particular, against gastro-intestinal infections.

Within the scope of the LISA study, a cohort study conducted from birth, 2,191 children were re-examined at age 6. Furthermore, the data of swimming-pool attendances during infancy were collated, while further data on childrens health and life-style factors was collected by parental interviews.

Those babies that had not taken part in swimming as infants showed in the first year of life a much lower infection rate, especially with diarrhoea *. However, no unequivocal connection could be produced between infant or frequent swimming-pool attendances and atopic diseases up to the age of six years. Indeed, an extensive control group of children who had not attended swimming-pools during the first six years is so far missing, but would be essential to draw conclusions about the long-term health impact of early swimming pool attendance.


'/>"/>

Contact: Heinz Joerg Haury
haury@gsf.de
49-893-187-2460
GSF - National Research Center for Environment and Health
Source:Eurekalert

Page: 1

Related biology news :

1. Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer
2. Light therapy may combat fungal infections, new evidence suggests
3. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
4. Researchers find first evidence of venom system in extinct mammal
5. Scientists find evidence of catastrophic sand avalanches, sea level changes in Gulf of Mexico
6. Oldest dated evidence of cattle in southern Africa found
7. SLU researchers uncover direct evidence on how HIV invades healthy cells
8. Same-sex mating by fungi spawned infection outbreak, evidence suggests
9. Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace
10. Why we give: New study finds evidence of generosity among our early human ancestors
11. New evidence supports century-old theory of cancer spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market Intelligence ... Biometrics and Digital Identity".  Acuity characterizes 2017 as ... when increased adoption reflects a new understanding of ... "Biometrics and digital identity are often perceived ... Maxine Most , Principal of Acuity Market intelligence. ...
(Date:1/23/2017)... , Jan. 23, 2017  The latest mobile ... smartphone prices have dropped dramatically. The quarterly average price ... 2013 to $276 in Q4 2016.  There are now ... price of $116, up from just 28 a year ... According to Maxine Most , Acuity Market ...
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today ... peptide drug candidates, PTG-100 and PTG-200, at the ... and Colitis Organization (ECCO).  The ECCO congress is ... from February 15 – 18, 2017. ... Protagonist drug candidates PTG-100 and PTG-200. PTG-100, a ...
(Date:2/16/2017)... 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... a better treatment for triple negative breast cancer (TNBC), announced ... France program. The YEi Start in ... to help entrepreneurs grow their business in France ... American companies selected to complete an intensive one week immersion ...
(Date:2/16/2017)... Feb. 16, 2017  ArmaGen, Inc., a privately ... to treat severe neurological disorders, today reported preliminary ... AGT-181, the company,s investigational therapy for the treatment ... mucopolysaccharidosis type I, or MPS I). The initial ... study, presented today at the 13 th ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
Breaking Biology Technology: